Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Angiodynamics (ANGO) Other Non-Current Liabilities (2016 - 2025)

Angiodynamics (ANGO) has disclosed Other Non-Current Liabilities for 14 consecutive years, with $17.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Non-Current Liabilities rose 43.88% year-over-year to $17.1 million, compared with a TTM value of $17.1 million through Nov 2025, up 43.88%, and an annual FY2025 reading of $16.9 million, up 5.14% over the prior year.
  • Other Non-Current Liabilities was $17.1 million for Q4 2025 at Angiodynamics, up from $14.2 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $17.4 million in Q1 2025 and bottomed at $3.0 million in Q3 2023.
  • Average Other Non-Current Liabilities over 5 years is $10.4 million, with a median of $8.9 million recorded in 2021.
  • The sharpest move saw Other Non-Current Liabilities crashed 64.74% in 2022, then skyrocketed 428.26% in 2024.
  • Year by year, Other Non-Current Liabilities stood at $7.7 million in 2021, then tumbled by 54.39% to $3.5 million in 2022, then decreased by 15.55% to $3.0 million in 2023, then soared by 298.29% to $11.9 million in 2024, then skyrocketed by 43.88% to $17.1 million in 2025.
  • Business Quant data shows Other Non-Current Liabilities for ANGO at $17.1 million in Q4 2025, $14.2 million in Q3 2025, and $16.9 million in Q2 2025.